SPARTHA Medical has been granted for CIR accreditation SPARTHA Medical is pleased to announce the company has been granted for CIR accreditation for research and development (R&D) after scientific and technical expertise. • What does it mean ? The Research Tax Credit … Read More
HOME
THE FIRST LINE OF VERSATILE, PERSONALISED
ANTIMICROBIAL, ANTIVIRAL
AND ANTI-INFLAMMATORY COATINGS
FOR MEDICAL DEVICES
FOR DAILY USE*
*Shown to inactivate SARS-CoV-2 (Covid-19)
Hospital Acquired Infections
0
%
of the cases are related with medical devices.
SPARTHA Medical has developed multifunctional coatings that can prevent
device related infection and diminish inflammation
without affecting the function of the medical device.
We offer customised coating development for producers with specific properties optimized for the target microenvironment
We develop a « coating kit » to be utilized directly in hospitals with respect to the patient immunoprofile
We develop a biocompatible spray for general/daily use
OUR STORY
SPARTHA Medical is a spin-off from INSERM UMR1121
a public research institute with more than 20 years of experience in development of coating.
SPARTHA Medical ’s core technologies
are based patented inventions coming from two European projects (IMMODGEL and PANBioRA) that started in 2013.
OUR TEAM
Our Multidisciplinary Team brings together Know-How and Expertise in :
| Medical Device Design and Development
| Coating Technologies
| BioTechnology Business Development
| Production and Regulatory Affairs
OUR SUPPORTS
SPARTHA Medical has a strong support from :
| University of Strasbourg | SATT Conectus | INSERM and our partners in the ongoing | PANBioRa project.
We are incubated in | SEMIA and financially supported by | Grand Est region (Start-up support) and | French Public Bank of Investment (BPI, i-Lab 2019)
PLEASE DO NOT HESITATE TO CONTACT US IF YOU REQUIRE ANY FURTHER INFORMATION
TAKE A LOOK AT OUR LATEST NEWS
Development of coatings using artificial intelligence: a world premiere.
Development of coatings using artificial intelligence: a world premiere. A collaboration between SPARTHA Medical, Preste and INSERM has resulted in publication of a pioneering paper in their areas of expertise in the journal Scientific Reports. Data from the scientific literature … Read More
SPARTHA Medical has been selected among the 100 startups to invest in by Challenges
‘100 startups to invest in’ selection Released each year by the magazine Challenges, the 2021 edition of the ‘100 startups to invest in’ selection has included SPARTHA Medical. The top 100 SPARTHA’s presentation ”Our selection in this ranking marks a … Read More